| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13D · 1 security · may seek to influence control | ||||||
|
Zenas BioPharma, Inc.
13D
ZBIO · 98937L105
|
5.1% |
5/5/2026
Event 4/29/2026
|
||||
| Moulder Leon O Jr | 5.1% | |||||
| Tellus BioVentures, LLC | 2.9% | |||||
| Leon O. Moulder, Jr. Revocable Trust U/A dtd 9/9/2008 | 0.1% | |||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.